
Cefobak-S 375 Injection
Marketer
Candela Healthcare
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Cefobak-S 375 Injection
Cefobak-S 375 Injection, a dual-action medication, combats various bacterial infections by inhibiting microbial proliferation and halting infection spread. Administration must be strictly under medical guidance; adhere rigorously to the prescribed dosage schedule. Complete the entire course, even with symptom improvement; premature cessation may compromise efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia; escalate any worsening symptoms to your physician immediately. Allergic reactions (rash, pruritus, edema, dyspnea) demand urgent medical attention. Disclose all current medications to your doctor before commencing treatment. Pregnant or lactating individuals should seek medical counsel prior to use. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing to driving ability, avoid operation of vehicles if drowsiness or dizziness occurs. Adequate rest, nutritious food, and sufficient hydration contribute to optimal recovery. Your doctor may order blood tests and other assessments to monitor treatment response.
Uses of Cefobak-S 375 Injection
Infections caused by bacteria
Major Benefits of Cefobak-S 375 Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Cefobak-S 375 Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Cefobak-S 375 Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Cefobak-S 375 Injection works:
Ceftriaxone and Sulbactam, the active components of Cefobak-S 375 Injection, act synergistically. Ceftriaxone, an antibiotic, disrupts bacterial cell wall synthesis, hindering bacterial survival. Sulbactam, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, thus optimizing Ceftriaxone's antibacterial effect.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions from concurrent use of Cefobak-S 375 Injection and alcohol.
PregnancySAFE IF PRESCRIBED
The injectable formulation of Cefobak-S 375 is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no negative consequences for fetal development; nevertheless, research involving human subjects is currently scant.
Breast feedingCAUTION
Administering Cefobak-S 375 Injection to breastfeeding mothers requires careful consideration. Mothers should temporarily discontinue breastfeeding throughout the course of treatment and until the medication is fully cleared from their system.
DrivingUNSAFE
Cefobak-S 375 Injection can cause drowsiness, blurred vision, and dizziness. Driving should be avoided if these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding Cefobak-S 375 Injection use in individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should use Cefobak-S 375 Injection cautiously, potentially requiring dosage modification. Mild to moderate liver dysfunction does not necessitate Cefobak-S 375 Injection dose alteration; however, medical consultation is advised in all cases of liver disease.
What if you forget to take Cefobak-S 375 Injection :
Omitting a dose of Cefobak-S 375 Injection necessitates contacting your physician.
Facts to Know About Cefobak-S 375 Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Anti-infective agents |
